Oxytocin-Trust Link in Oxytocin-Sensitive Participants and Those Without Autistic Traits

There have been numerous studies in which the biological role of oxytocin in trusting behavior has been investigated. However, a link between oxytocin and trust in humans was discovered only in one early study. We hypothesized that there is a large interindividual variation in oxytocin sensitivity,...

Full description

Bibliographic Details
Main Authors: Hirofumi Kurokawa, Yusuke Kinari, Hiroko Okudaira, Kiyotaka Tsubouchi, Yoshimichi Sai, Mitsuru Kikuchi, Haruhiro Higashida, Fumio Ohtake
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnins.2021.659737/full
_version_ 1818647607507943424
author Hirofumi Kurokawa
Yusuke Kinari
Hiroko Okudaira
Kiyotaka Tsubouchi
Yoshimichi Sai
Mitsuru Kikuchi
Haruhiro Higashida
Fumio Ohtake
author_facet Hirofumi Kurokawa
Yusuke Kinari
Hiroko Okudaira
Kiyotaka Tsubouchi
Yoshimichi Sai
Mitsuru Kikuchi
Haruhiro Higashida
Fumio Ohtake
author_sort Hirofumi Kurokawa
collection DOAJ
description There have been numerous studies in which the biological role of oxytocin in trusting behavior has been investigated. However, a link between oxytocin and trust in humans was discovered only in one early study. We hypothesized that there is a large interindividual variation in oxytocin sensitivity, and that such variation is one reason for the doubt surrounding the role of oxytocin in trusting behavior. Here, in a double-blind, prospective, case-control study, we administered intranasal oxytocin to participants of trust and risk games. We measured salivary oxytocin concentration, relating it to the amount of money transferred among participants (a proxy for trust) and the autism-spectrum quotient (AQ). A one-sided Fisher’s exact test was performed to detect differences between the oxytocin and placebo groups in the proportions of investors who transferred the maximum amount of money. We discovered a tendency for participants who received oxytocin to transfer higher amounts of money to co-participants than those who received a placebo (P = 0.04). We also revealed a high degree of interindividual variation in salivary oxytocin concentrations after oxytocin administration. After stratifying the samples with respect to oxytocin sensitivity, oxytocin-sensitive participants in the oxytocin group also transferred higher amounts of money than those in the placebo group (P = 0.03), while such a tendency was not observed for oxytocin-insensitive participants (P = 0.34). Participants with lower AQ scores (less severe autistic traits) exhibited a greater tendency toward trusting behavior after oxytocin administration than did those with higher AQ scores (P = 0.02). A two-sample t-test that was performed to detect significant differences in the mean transfers between the oxytocin and placebo groups indicated no significant between-group difference in the mean transfers (P = 0.08). There are two possible interpretations of these results: First, there is no effect of oxytocin on trust in humans; second, the effects of oxytocin on trust in humans is person-dependent. However, the results should be interpreted with caution as the effect size was not larger than the minimal detectable effect size and the results were not statistically significant (P > 0.05) after Bonferroni corrections.
first_indexed 2024-12-17T01:05:13Z
format Article
id doaj.art-f5ffffc8f0294613a754141ad71bb5d4
institution Directory Open Access Journal
issn 1662-453X
language English
last_indexed 2024-12-17T01:05:13Z
publishDate 2021-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neuroscience
spelling doaj.art-f5ffffc8f0294613a754141ad71bb5d42022-12-21T22:09:18ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2021-05-011510.3389/fnins.2021.659737659737Oxytocin-Trust Link in Oxytocin-Sensitive Participants and Those Without Autistic TraitsHirofumi Kurokawa0Yusuke Kinari1Hiroko Okudaira2Kiyotaka Tsubouchi3Yoshimichi Sai4Mitsuru Kikuchi5Haruhiro Higashida6Fumio Ohtake7School of Economics and Management, University of Hyogo, Kobe, JapanHirao School of Management, Konan University, Nishinomiya, JapanDoshisha Business School, Doshisha University, Kyoto, JapanDepartment of Hospital Pharmacy, Kanazawa University, Kanazawa, JapanDepartment of Hospital Pharmacy, Kanazawa University, Kanazawa, JapanDepartment of Psychiatry and Neurobiology, Graduate School of Medical Science, Kanazawa University, Kanazawa, JapanResearch Center for Child Mental Development, Kanazawa University, Kanazawa, JapanCenter for Infectious Disease Education and Research, Osaka University, Suita, JapanThere have been numerous studies in which the biological role of oxytocin in trusting behavior has been investigated. However, a link between oxytocin and trust in humans was discovered only in one early study. We hypothesized that there is a large interindividual variation in oxytocin sensitivity, and that such variation is one reason for the doubt surrounding the role of oxytocin in trusting behavior. Here, in a double-blind, prospective, case-control study, we administered intranasal oxytocin to participants of trust and risk games. We measured salivary oxytocin concentration, relating it to the amount of money transferred among participants (a proxy for trust) and the autism-spectrum quotient (AQ). A one-sided Fisher’s exact test was performed to detect differences between the oxytocin and placebo groups in the proportions of investors who transferred the maximum amount of money. We discovered a tendency for participants who received oxytocin to transfer higher amounts of money to co-participants than those who received a placebo (P = 0.04). We also revealed a high degree of interindividual variation in salivary oxytocin concentrations after oxytocin administration. After stratifying the samples with respect to oxytocin sensitivity, oxytocin-sensitive participants in the oxytocin group also transferred higher amounts of money than those in the placebo group (P = 0.03), while such a tendency was not observed for oxytocin-insensitive participants (P = 0.34). Participants with lower AQ scores (less severe autistic traits) exhibited a greater tendency toward trusting behavior after oxytocin administration than did those with higher AQ scores (P = 0.02). A two-sample t-test that was performed to detect significant differences in the mean transfers between the oxytocin and placebo groups indicated no significant between-group difference in the mean transfers (P = 0.08). There are two possible interpretations of these results: First, there is no effect of oxytocin on trust in humans; second, the effects of oxytocin on trust in humans is person-dependent. However, the results should be interpreted with caution as the effect size was not larger than the minimal detectable effect size and the results were not statistically significant (P > 0.05) after Bonferroni corrections.https://www.frontiersin.org/articles/10.3389/fnins.2021.659737/fulloxytocinhumantrustinterindividual variationsaliva
spellingShingle Hirofumi Kurokawa
Yusuke Kinari
Hiroko Okudaira
Kiyotaka Tsubouchi
Yoshimichi Sai
Mitsuru Kikuchi
Haruhiro Higashida
Fumio Ohtake
Oxytocin-Trust Link in Oxytocin-Sensitive Participants and Those Without Autistic Traits
Frontiers in Neuroscience
oxytocin
human
trust
interindividual variation
saliva
title Oxytocin-Trust Link in Oxytocin-Sensitive Participants and Those Without Autistic Traits
title_full Oxytocin-Trust Link in Oxytocin-Sensitive Participants and Those Without Autistic Traits
title_fullStr Oxytocin-Trust Link in Oxytocin-Sensitive Participants and Those Without Autistic Traits
title_full_unstemmed Oxytocin-Trust Link in Oxytocin-Sensitive Participants and Those Without Autistic Traits
title_short Oxytocin-Trust Link in Oxytocin-Sensitive Participants and Those Without Autistic Traits
title_sort oxytocin trust link in oxytocin sensitive participants and those without autistic traits
topic oxytocin
human
trust
interindividual variation
saliva
url https://www.frontiersin.org/articles/10.3389/fnins.2021.659737/full
work_keys_str_mv AT hirofumikurokawa oxytocintrustlinkinoxytocinsensitiveparticipantsandthosewithoutautistictraits
AT yusukekinari oxytocintrustlinkinoxytocinsensitiveparticipantsandthosewithoutautistictraits
AT hirokookudaira oxytocintrustlinkinoxytocinsensitiveparticipantsandthosewithoutautistictraits
AT kiyotakatsubouchi oxytocintrustlinkinoxytocinsensitiveparticipantsandthosewithoutautistictraits
AT yoshimichisai oxytocintrustlinkinoxytocinsensitiveparticipantsandthosewithoutautistictraits
AT mitsurukikuchi oxytocintrustlinkinoxytocinsensitiveparticipantsandthosewithoutautistictraits
AT haruhirohigashida oxytocintrustlinkinoxytocinsensitiveparticipantsandthosewithoutautistictraits
AT fumioohtake oxytocintrustlinkinoxytocinsensitiveparticipantsandthosewithoutautistictraits